RAP 0.00% 20.5¢ raptor resources limited

Ann: ResAppDx-EU in Use at COVID-19 Respiratory Clinic, page-27

  1. 434 Posts.
    lightbulb Created with Sketch. 319
    I wonder how many Doctors worldwide could use this right now...

    “Our doctors have found ResAppDx-EU invaluable in helping them make differential diagnoses of respiratory disease. Being a non-contact diagnostic aid, ResAppDx-EU is especially useful when assessing patients in the difficult conditions associated with managing possible COVID-19 cases.”
 
watchlist Created with Sketch. Add RAP (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.